sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK

Ultrasound in Obstetrics and Gynecology

Volumn 48, Issue 6, 2016, Pages 765-771

  Vatish, M ^a   Strunz McKendry, T ^b   Hund, M ^c   Allegranza, D ^c   Wolf, C ^c   Smare, C ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Applied Science Department   (United Kingdom)

^c Roche Diagnostics Ltd   (Switzerland)

^d PAREXEL INTERNATIONAL   (United States)

Author keywords

cost effectiveness; diagnosis; economic; hospitalization; model; pre eclampsia; prediction; sFlt 1 PlGF

Indexed keywords

BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PIGF PROTEIN, HUMAN; VASCULOTROPIN RECEPTOR 1;

COST BENEFIT ANALYSIS; ECONOMIC MODEL; ECONOMICS; FEMALE; HUMAN; METABOLISM; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; UNITED KINGDOM;

BIOMARKERS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MEMBRANE PROTEINS; MODELS, ECONOMIC; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; UNITED KINGDOM; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 85000925818     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15997     Document Type: Article

References (21)

1. National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy (NICE clinical guideline 107). NICE, 2011.
2. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25: 391–403.
3. Liu A, Wen SW, Bottomley J, Walker MC, Smith G. Utilization of health care services of pregnant women complicated by preeclampsia in Ontario. Hypertens Pregnancy 2009; 28: 76–84.
4. Delahaije DH, Smits LJ, van Kuijk SM, Peeters LL, Duvekot JJ, Ganzevoort W, Oudjik MA, van Pampus MG, Scheepers HC, Spaanderman ME, Dirksen CD. Care-as-usual provided to formerly preeclamptic women in the Netherlands in the next pregnancy: health care consumption, costs and maternal and child outcome. Eur J Obstet Gynecol Reprod Biol 2014; 179: 240–245.
5. Shennan AH, Redman C, Cooper C, Milne F. Are most maternal deaths from pre-eclampsia avoidable? Lancet 2012; 379: 1686–1687.
6. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012; 206: 58.e1–8.
7. Schiettecatte J, Russcher H, Anckaert E, Mees M, Leeser B, Tirelli AS, Fiedler GM, Luthe H, Denk B, Smitz J. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem 2010; 43: 768–770.
8. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, Pape J, Dudenhausen JW, Denk B, Stepan H. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010; 202: 161.e1–161.e11.
9. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, Galindo A, Schoofs K, Denk B, Stepan H. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014; 63: 346–352.
10. Hund M, Verhagen-Kamerbeek W, Reim M, Messinger D, van der Does R, Stepan H. Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia – the PreOS study protocol. Hypertens Pregnancy 2015; 34: 102–115.
11. th World Congress on Controversies in Obstetrics, Gynecology and Infertility 2014, Paris. Abstract P54.
12. Klein E, Schlembach D, Ramoni A, Langer E, Bahlmann F, Grill S, Schaffenrath H, van der Does R, Messinger D, Verhagen-Kamerbeek WD, Reim M, Hund M, Stepan H. Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia. PLoS One 2016; 11: e0156013. doi: 10.1371/journal.pone.0156013.
13. Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth 2014; 14: 324.
14. Verlohren S, Llurba E, Chantraine F, Vatish M, Staff A, Sennström M, Olovsson M, Brennecke S, Stepan H, Allegranza D, Schoedl M, Dilba P, Hund M, Zeisler H. The sFlt-1/PlGF ratio can rule out preeclampsia up to four weeks in women with suspected preeclampsia. ISSHP XX World Congress 2016, Sao Paulo, Brazil. Submitted abstract.
15. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, Olovsson M, Brennecke SP, Stepan H, Allegranza D, Dilba P, Schoedl M, Hund M, Verlohren S. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 2016; 374: 13–22.
16. Stepan H, Herraiz I, Schlembach D, Verlohren S, Brennecke S, Chantraine F, Klein E, Lapaire O, Llurba E, Ramoni A, Vatish M, Wertaschnigg D, Galindo A. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol 2015; 45: 241–246.
17. NHS. PbR tariff information spreadsheet for 2013–2014. https://www.gov.uk/government/publications/payment-by-results-pbr-operational-guidance-and-tariffs [Accessed July 2016].
18. Office for National Statistics. Births in England and Wales, 2014. http://www.ons.gov.uk/ons/dcp171778_410897.pdf [Accessed October 2015].
19. DGGG. Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. http://www.awmf.org/uploads/tx_szleitlinien/015-018l_S1_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2014‐verlaengert.pdf [Accessed July 2016].
20. Hadker N, Garg S, Costanzo C, Miller JD, Foster T, van der Helm W, Creeden J. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective. J Med Econ 2010; 13: 728–737.
21. National Institute for Health and Care Excellence (NICE). PlGF-based testing to help diagnose suspected pre-eclampsia (Triage PlGF test, Elecsys immunoassay sFlt-1/PlGF ratio, DELFIA Xpress PlGF 1-2-3 test, and BRAHMS sFlt-1 Kryptor/BRAHMS PlGF plus Kryptor PE ratio): NICE diagnostics guidance [DG23]. 2016 https://www.nice.org.uk/guidance/dg23/chapter/1-Recommendations [Accessed May 2016].